Article Navigation

Back To Main Page


 

More Articles

Why Child Bearing Is Healthy


by: Dr Randy Wysong

From a purely biological perspective, bearing children can be considered the most important reason for a woman’s existence. For that matter, the same could be said about men, since both sexes are, in effect, disposable packages of genetic material. We die, but our genes continue on immortally.

With increasing population pressure and modern independent lifestyles (unlike the family farm where children were almost a necessity), procreation has become an option that is increasingly declined or at least significantly restricted. But with these choices women take themselves out of a natural biological role. Additionally, treating the breast as an ornament rather than a feeding organ – by opting for synthetic formulas – also removes women from a natural biological function.

When these choices are coupled with the use of contraceptive hormones, hormone replacement therapy, an increasing load of estrogenic pollutants in the environment and food, and a diet that has veered significantly from its natural design, the formula for hormonal pandemonium, metabolic dysfunction, and disease is in place. The result is early menses in children, infertility, abnormal and erratic menstrual cycles, cervical dysplasia, fibroids, endometrial cancer, breast cancer, premenstrual syndrome, dramatic mood swings and depression, osteoporosis, and other symptoms of abnormal menopause: hot flashes, psychological problems, decreased libido, and thinning of the vaginal wall.

This is a difficult problem with no easy solution. If women would have as many children as they are capable of, nurse them for years as they are designed to, eat natural foods, and live in a more pristine environment, most of these modern health problems would disappear.

If money flowed out of our tap we would not have economic problems either, right?

The desire to limit families may soon not even be an option. We either curtail population growth or we will saw through the branch we all sit on. Population is the engine that ultimately drives all environmental woes. We live on a finite planet with finite resources, but we have an infinite ability to breed. We either live within the limits of Earth’s sustainable resources or we will destroy ourselves. Having children may be a natural and healthy process, but can be a deadly game for sustainable life on Earth.

So we have a conundrum. Women need to fulfill their biological reproductive role to achieve metabolic balance and health, but if they do so unlimited, the health of life on Earth is jeopardized.

In an attempt to solve this dilemma, women have turned to the quick fix of pharmaceutical synthetic hormones. Hormones that control conception, hormones that control abnormal menstrual cycles, and hormones that fix menopause. It is an overly simplistic solution to a complex problem.

The saying, “Don’t mess with Mother Nature” is particularly applicable when dosing the body with hormones. Since the 1940’s when estrogen therapy became popular, hundreds of thousands of women have succumbed to cancer. For example, a woman is nearly 13 times more likely to get endometrial cancer, and at nearly a 30% increased risk of breast cancer when she takes estrogen. Recently, researchers have identified the two top preventable breast cancer risks: oral birth control pills and estrogen replacement therapy.

For those who justify the use of estrogen for the benefits of decreased risk of osteoporosis and cardiovascular disease, consider that proper exercise, diet and lifestyle choices can have the same beneficial effect without the potential consequence of cancer.

How have women specifically put themselves outside of their natural context to make themselves more susceptible to cancers?

The average mom gives birth to about two infants. Although this is an intelligent number from the standpoint of population control, it is unnatural in that by not continuing to have pregnancies and to nurse (which stops ovulations) she will ovulate an incredible 438 times during her lifetime.

On the other hand, a woman in the primitive natural setting who may not even know what causes pregnancy or how to prevent it even if they wanted to, would have started menstruating and ovulating at age twelve and would have delivered nine babies and breast-fed them over the course of her reproductive career. Breast-feeding can continue for children in a totally natural setting for up to five or more years of age. The combination of pregnancy along with breast-feeding in the premodern setting would have decreased the number of ovulations that a primitive mother would have had to about nine.

This means that today women cycle through their menstrual periods an abnormal number of times, subjecting their bodies to surges of estrogen 50 times greater than our primitive ancestors living in a natural setting.

Many cancers of women are sensitive to high levels of female hormones.

For example, breast cancer is sensitive to estrogen. In dogs, simply removing the ovaries can often prevent or halt the progress of mammary cancer. Tamoxifen in humans is used to block estrogen activity within the mammary glands and thus is believed to exert its protective effect in this way. (This pharmaceutical agent can, however, increase the risk of uterine cancer to about the same degree that the risk of breast cancer is reduced!)

The resting periods of lower estrogen levels that women experienced in the premodern setting served a protective effect to spare organs and tissues from cancer. Women who nurse for a total period of time of even as little as two years are known to have a decreased incidence of mammary cancer.

This excess ovulation hypothesis is the likely explanation for the tragic phenomenon of modern female cancers. When humans decide to flout and repudiate nature by interfering with natural biological design, disease will always be the consequence.

If the problem is a departure from nature, then the solution is a return to it. Here are some options:

1. Refer to the Wysong Optimal Health Program for guidelines on life choices that can enhance overall health and thus hormonal health (http://www.wysong.net/PDFs/ohp.pdf).

2. Emphasize fresh raw foods in the diet and avoid processed foods as much as possible.

3. Eliminate hydrogenated oils and refined sugars. Hydrogenated oils displace healthful dietary fats and have been shown to be carcinogenic, and sugars can stimulate a rise in estrogens.

4. Try to use organic foods as much as possible and avoid synthetic materials in cosmetics, at home and in the workplace to help reduce exposure to environmental estrogens.

5. Do not attempt “low fat” or “low cholesterol” fad diets that often create dependence upon processed carbohydrates and seriously reduce important natural dietary fats and essential fatty acids.

6. Increase the consumption of natural vegetable foods containing phytoestrogens which tend to counteract estrogens.

7. Avoid hormone medications if at all possible.

8. Explore natural birth control measures.

9. Nurse your babies for as long as you can.

Modern life presents many choices, freedoms and rights. Tinkering with child bearing, however, is a choice that is not without consequences. Women need to be aware and take the steps necessary to make sure the choices they make do not also bring with them the increased risk of serious modern diseases.

Reference:
Zeneca Pharaceuticals. Tamoxifen Patient Insert. Zeneca, Inc. Wilmington, DE. 1998.






Latest Cancer News:



FDA panel votes against Xgeva for prostate cancer


A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients Breast cancer kills older women more often


NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed with a certain type of breast cancer, those over 75 years old were 63 percent more likely to die of the cancer than women younger than 65. "I suspect it's ... Breast cancer charity chases Komen defectors


As a prominent breast cancer researcher and activist, Susan Love is no stranger to the Susan G. Komen Foundation. Love runs a breast cancer research foundation that bears her name, and she organized the Army of Women , more than 360,000 women to whom breast cancer researchers can blast out requests for subjects. But the Komen Foundation is so entrenched in the world of breast cancer fundraising ... A Better Way to Spend Breast Cancer Funds?


We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. Cancer-hit cricketer Yuvraj vows to return stronger


India's cancer-stricken World Cup hero Yuvraj Singh has vowed to return "stronger than ever" to competitive cricket, saying he was responding well to treatment in the United States. Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 http://www.reportlinker.com/p0657184/Doxil/Caelyx-Ovarian-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyDoxil/Caelyx ... Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines http://www.reportlinker.com/p0284988/Triple-Analysis-Lung-Cancer-Angiogenesis-and-Cancer-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ... Marian Regional Medical Center Receives CEO Cancer Gold Standard Accreditation


The CEO Roundtable on Cancer recently accredited Marian Regional Medical Center with the CEO Cancer Gold Standard? recognizing the hospital?s efforts to reduce the risk of cancer f Breast Cancer Drug May Weaken Bones, Study Finds


TUESDAY, Feb. 7 (HealthDay News) -- A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds. Marc Garnick Answers 6 Key Questions about Prostate Cancer


Marc Garnick Answers 6 Key Questions about Prostate Cancer Breast cancer kills older women more often - Fox News


News Image
Daily Mail

News Image
Breast cancer kills older women more often
Fox News
Print Email Share Comments Recommend Tweet Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed ...
Breast cancer kills older women more often: studyReuters
Older women at breast cancer death riskTimes of India
Breast cancer screening 'no longer justified' and causes 7000 women a year to ...Daily Mail
ABC News -Tempo
all 100 news articles »
Insight: Komen charity under microscope for funding, science - Reuters


News Image
Los Angeles Times

News Image
Insight: Komen charity under microscope for funding, science
Reuters
By Sharon Begley and Janet Roberts | NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it ...
Komen Board's Wisdom Lost on Scott WalkerHuffington Post (blog)
Komen foundation shouldn't give any money to Planned ParenthoodBaltimore Sun
Komen executive quits as questions persistLos Angeles Times

all 3,873 news articles »
FDA panel votes against Xgeva for prostate cancer - The Associated Press


News Image
USA TODAY

News Image
FDA panel votes against Xgeva for prostate cancer
The Associated Press
WASHINGTON (AP) ? A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients The Food and ...
Amgen Fails to Win Advisory Panel Backing for Expanded Use of Cancer DrugBloomberg
FDA questions Amgen drug for prostate cancerUSA TODAY
FDA Panel Votes Against Expanding Use Of Amgen Drug XgevaFox Business

all 87 news articles »
Pa. woman gets probation for fake cancer claims - USA TODAY



News Image
Pa. woman gets probation for fake cancer claims
USA TODAY
(AP) ? A Pennsylvania woman who submitted nearly $100000 worth of fake cancer treatment insurance claims for herself and her husband must repay the money while she serves nearly nine years on probation. The Observer-Reporter of Washington, ...

and more »
program takes cancer patients on Road to Recovery - Chicago Daily Herald



News Image
program takes cancer patients on Road to Recovery
Chicago Daily Herald
By Elisabeth Mistretta Kathy Miller of Arlington Heights sat inside Northwest Community Hospital near her home two years ago, feeling beaten down from radiation and chemotherapy treatments to treat her stage-four throat cancer.
Winter adds to ordeal of cancer patientsSTLtoday.com

all 2 news articles »
Slow-Growing Prostate Cancer Is Still 'Real Cancer' - Medscape



News Image
Slow-Growing Prostate Cancer Is Still 'Real Cancer'
Medscape
February 8, 2012 ? Low-grade low-volume prostate cancer often grows very slowly, and men presenting with this diagnosis might never experience morbidity or mortality as a result of the condition. However, hearing the emotionally charged term "cancer" ...
Ask Dr. K: Hot flashes in men are caused by low testosteroneGreenville Daily Reflector

all 3 news articles »
DNA sequencing helps identify cancer cells for immune system attack - Washington University in St. Louis News


News Image
Washington University in St. Louis News

News Image
DNA sequencing helps identify cancer cells for immune system attack
Washington University in St. Louis News
By Michael C. Purdy DNA sequences from tumor cells can be used to direct the immune system to attack cancer, according to scientists at Washington University School of Medicine in St. Louis. The research, in mice, appears online Feb. 8 in Nature.

and more »
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center - Sacramento Bee



News Image
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center
Sacramento Bee
Montblanc and Texas Children's Cancer Center have joined together to support excellence in patient care, research and education to enhance the health and well being of our nation's children. To show personal commitment to this cause, Montblanc has ...
Texas Children's partners with Montblanc to raise fundsHouston Business Journal

all 8 news articles »
Breast cancer claims Purdue astronaut Janice Voss, 55 - Journal and Courier


News Image
RedOrbit

News Image
Breast cancer claims Purdue astronaut Janice Voss, 55
Journal and Courier
Astronaut Janice E. Voss, a Purdue University graduate and one of the few women launched into space, died Monday in Scottsdale, Ariz., after a battle with breast cancer. She was 55. Voss was part of five space shuttle missions, spending a total of 49 ...
Cancer Claims Five-Time Shuttle AstronautDiscovery News
Janice Voss, Shuttle Astronaut, Dies of Cancer at 55ThirdAge
NASA Astronaut Janice Voss Loses Battle Against Breast CancerRedOrbit
WIFR -French Tribune -Boston.com
all 190 news articles »
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review - Fox Business


News Image
Insciences Organisation

News Image
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review
Fox Business
VX) experimental breast cancer drug pertuzumab, opening the way for a launch as early as 2012 for a product the Swiss company hopes can contain damage from lost sales when top seller Herceptin loses patent protection in a few years' time.
Roche breast cancer drug gets FDA priority reviewMarketWatch
FDA rewards Roche with priority review for blockbuster cancer drugFierceBiotech
FDA will speed up review of Roche cancer drugCBS News
PMLiVE -HemOncToday
all 53 news articles »

 



Home | Resource Links | Contact Us
Copyright © 2006 CancerAdvice.org